Uncategorized

Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma

by Business Wire • 2022/01/12 • 0 Comments

FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced the publication of a study in Ocular Oncology and Pathology related to the Company's DecisionDx®-UMSeq 7-gene DNA sequencing panel.

← Global Posterior Segment Eye Disorders Market (2020 to 2025) – Growth, Trends and Forecasts – ResearchAndMarkets.com

Worldwide Corneal Topographers Industry to 2027 – Increasing Number of LASIK Surgeries Across the World is Driving Growth – ResearchAndMarkets.com →

Post navigation